On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2
出版年份 2020 全文链接
标题
On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2
作者
关键词
-
出版物
Cell Death & Disease
Volume 11, Issue 8, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-08-19
DOI
10.1038/s41419-020-02842-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model
- (2020) Hua-Hao Fan et al. CHINESE MEDICAL JOURNAL
- Covid-19 transmission, outcome and associated risk factors in cancer patients at the first month of the pandemic in a Spanish hospital in Madrid
- (2020) J. Rogado et al. Clinical & Translational Oncology
- In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- (2020) Xueting Yao et al. CLINICAL INFECTIOUS DISEASES
- Drug-specific risk of severe QT prolongation following acute drug overdose
- (2020) Sharan L. Campleman et al. CLINICAL TOXICOLOGY
- Repositionnement de la chlorpromazine dans le traitement du COVID-19 : étude reCoVery
- (2020) M. Plaze et al. ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE
- Repurposing of chloroquine and some clinically approved antiviral drugs as effective therapeutics to prevent cellular entry and replication of coronavirus
- (2020) Akinwunmi O. Adeoye et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Proteomics of SARS-CoV-2-infected host cells reveals therapy targets
- (2020) Denisa Bojkova et al. NATURE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Compassionate Use of Remdesivir for Patients with Severe Covid-19
- (2020) Jonathan Grein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system
- (2020) Shuofeng Yuan et al. PHARMACOLOGICAL RESEARCH
- An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
- (2020) Timothy P. Sheahan et al. Science Translational Medicine
- Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets
- (2020) Su-Jin Park et al. mBio
- Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
- (2020) Philippe Gautret et al. Travel Medicine and Infectious Disease
- Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
- (2020) Wei Tang et al. BMJ-British Medical Journal
- Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data
- (2020) Matthieu Mahévas et al. BMJ-British Medical Journal
- Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)
- (2020) Nicholas J. Mercuro et al. JAMA Cardiology
- Pharmacological Therapeutics Targeting RNA-Dependent RNA Polymerase, Proteinase and Spike Protein: From Mechanistic Studies to Clinical Trials for COVID-19
- (2020) Jiansheng Huang et al. Journal of Clinical Medicine
- The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
- (2020) Leon Caly et al. ANTIVIRAL RESEARCH
- Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
- (2020) Ka-Tim Choy et al. ANTIVIRAL RESEARCH
- Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARS-CoV-2 and other acute viral infections: a systematic review and meta-analysis
- (2020) Wei Liu et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
- (2020) David R. Boulware et al. NEW ENGLAND JOURNAL OF MEDICINE
- Three kinds of treatment with Homoharringtonine, Hydroxychloroquine or shRNA and their combination against coronavirus PEDV in vitro
- (2020) Cui-Cui Li et al. Virology Journal
- Identification of a novel autophagic inhibitor cepharanthine to enhance the anti-cancer property of dacomitinib in non-small cell lung cancer
- (2018) Zheng-Hai Tang et al. CANCER LETTERS
- Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors
- (2018) Jeanne M. Sisk et al. JOURNAL OF GENERAL VIROLOGY
- Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression
- (2016) Savina Apolloni et al. Journal of Neuroinflammation
- Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion
- (2016) Christopher M. Coleman et al. JOURNAL OF VIROLOGY
- Generic imatinib — impact on frontline and salvage therapy for CML
- (2016) Larry Gorkin et al. Nature Reviews Clinical Oncology
- Immunological off-target effects of imatinib
- (2016) Laurence Zitvogel et al. Nature Reviews Clinical Oncology
- A cell-based quantitative high-throughput image screening identified novel autophagy modulators
- (2016) Yuan Li et al. PHARMACOLOGICAL RESEARCH
- The Contribution of Lysosomotropism to Autophagy Perturbation
- (2013) Roshan Ashoor et al. PLoS One
- Siramesine triggers cell death through destabilisation of mitochondria, but not lysosomes
- (2013) M Hafner Česen et al. Cell Death & Disease
- Haloperidol and clozapine block formation of autophagolysosomes in rat primary neurons
- (2012) J. Park et al. NEUROSCIENCE
- The Management of Gastrointestinal Stromal Tumors: A Model for Targeted and Multidisciplinary Therapy of Malignancy
- (2011) Heikki Joensuu et al. Annual Review of Medicine
- Fluorescent Derivatives of σ Receptor Ligand 1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) as a Tool for Uptake and Cellular Localization Studies in Pancreatic Tumor Cells
- (2011) Carmen Abate et al. JOURNAL OF MEDICINAL CHEMISTRY
- ChemmineR: a compound mining framework for R
- (2008) Y. Cao et al. BIOINFORMATICS
- Lysosomal membrane permeabilization in cell death
- (2008) P Boya et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now